newsfilter
← Latest News
Business Wire·

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' today announced it entered into an agreement with PCI Pharma Services (PC